Thursday, July 22, 2021

Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item

Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item The core biologics segment reported revenue growth of 10 percent YoY at Rs 758 crore in Q1FY22, led by strong growth especially in India and other markets, especially biosimilars associated with Covid- care such as Itolizumab and Bevacizumab.

from Moneycontrol Business News https://ift.tt/3zotfBG
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...